Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Sanandan Patel"'
Publikováno v:
South Asian Journal of Cancer, Vol 8, Iss 1, Pp 52-56 (2019)
Context: Nimotuzumab is the only anti-epidermal growth factor receptor monoclonal antibody which can be safely added to concurrent chemoradiotherapy (CRT) to improve efficacy in the management of unresectable, locally advanced squamous cell carcinoma
Externí odkaz:
https://doaj.org/article/95465b89121d4c5c888d682757d14b69
Autor:
ChaitaliM Waghmare, Sanandan Patel, MukundB Sarje, ShailendraMohan Jain, VandanaShailendra Jain, Mayuresh Virkar
Publikováno v:
Journal of cancer research and therapeutics. 18(6)
This study aims to evaluate the efficacy, feasibility, tolerability, and toxicity of concurrent chemotherapy and brachytherapy for locally advanced cervical carcinoma.Forty patients of cervical carcinoma were included in this study. The study period
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a60837f6033f18820f87ad47cf6a27da
https://pubmed.ncbi.nlm.nih.gov/36412413
https://pubmed.ncbi.nlm.nih.gov/36412413
Autor:
Sanandan Patel
Publikováno v:
Journal of Medical Science And clinical Research. 7
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9538abfa6ebb19ae34073dcc2bf51962
https://doi.org/10.18535/jmscr/v7i5.95
https://doi.org/10.18535/jmscr/v7i5.95
Autor:
Sanandan Patel
Publikováno v:
Journal of Medical Science And clinical Research. 6
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2263640755d45f1aac800cbfc0446a6b
https://doi.org/10.18535/jmscr/v6i12.15
https://doi.org/10.18535/jmscr/v6i12.15
Publikováno v:
Medico Research Chronicles. 6:316
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4dead4ee866f4a11c8e853d261213b0a
https://doi.org/10.26838/medrech.2019.6.6.538
https://doi.org/10.26838/medrech.2019.6.6.538